PRNewswire/ -- ("Kos"), a global life sciences investment firm bridging the U.S. and European biopharma ecosystems, today ...

Many bioentrepreneurs incorrectly estimate the value of their technology by failing to account adequately for the cost, risk, ...

Vir Biotechnology (VIR) has signed a collaboration and license agreement with Gilead focused on three PRO-XTEN dual-masked ...

Vir Biotechnology will host its third quarter 2026 financial results conference call at 4:30 p.m. ET / 1:30 p.m. PT today. A ...

<?xml encoding="utf-8" ?> Vir Biotechnology VIR reported third-quarter financial results on Wednesday. The transcript from ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable manufacturing platform capable of reshaping the future of food production through ...

(Nasdaq: VIR), today announced the appointment of Suzanne Topalian, M.D., to its Board of Directors, effective October 27, ...

The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export curbs on cutting edge biotech innovations.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

WPI offers more than 70 degree and certificate programs to meet a range of academic interests. More than three dozen academic departments and programs give students options to explore their varying ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...